Vimarsana
Biggest News Aggregation in the World

Page 23 - Iontech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iontech Today - Breaking & Trending Today

Coronavirus vaccine: Hong Kong rolls out BioNTech jabs for children aged 6 months to under 5 years, minister warns booking rate low - Vimarsana News

Coronavirus vaccine: Hong Kong rolls out BioNTech jabs for children aged 6 months to under 5 years, minister warns booking rate low

Secretary for the Civil Service Ingrid Yeung says take-up rate ‘not ideal’ in light of low overall vaccination figures among city’s children aged under three years.

Source: scmp.com
EarthCam Delivers a Suite of 21 New Features for Procore at - Vimarsana News

EarthCam Delivers a Suite of 21 New Features for Procore at

Introducing jobsite Door Cam security, live weather and PPE alerts for new Daily Log sections...

Coronavirus: bookings for BioNTech vaccine for children aged six months to under 5 years will open on Sunday, 4 centres in Hong Kong offering jabs - Vimarsana News

Coronavirus: bookings for BioNTech vaccine for children aged six months to under 5 years will open on Sunday, 4 centres in Hong Kong offering jabs

Shots available at Hong Kong Children’s Hospital, Gleneagles Hospital, CUHK Medical Centre and Osman Ramju Sadick Memorial Sports Centre.

Source: scmp.com
Pfizer Inc.: Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine - Vimarsana News

Pfizer Inc.: Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine

Bivalent booster elicited approximately 4-fold higher neutralizing antibody titers against Omicron BA.4/BA.5 sublineages compared to the original COVID-19 vaccine in individuals older than 55 years

Pfizer, BioNTech Reveal Updated Data For Omicron BA.4/BA.5-Adapted Bivalent Booster - Vimarsana News

Pfizer, BioNTech Reveal Updated Data For Omicron BA.4/BA.5-Adapted Bivalent Booster

NEW YORK CITY (dpa-AFX) - Drug major Pfizer Inc. (PFE) and German partner BioNTech SE (BNTX) announced Friday updated data from a Phase 2/3 clinical trial for Omicron BA.4/BA.5-adapted bivalent